# Evaluation of All'InCath in Peripheral Vasculature Percutaneous Transluminal Angioplasty.

> **NCT05153421** · NA · TERMINATED · sponsor: **NexStep Medical** · enrollment: 30 (actual)

## Conditions studied

- Vascular Diseases

## Interventions

- **DEVICE:** All'InCath CBC 035M Balloon Dilatation Catheter

## Key facts

- **NCT ID:** NCT05153421
- **Lead sponsor:** NexStep Medical
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2021-05-06
- **Primary completion:** 2024-12-06
- **Final completion:** 2024-12-06
- **Target enrollment:** 30 (ACTUAL)
- **Why stopped:** As part of the new regulatory requirements in Europe and in accordance with the MDR regulation set to take effect on January 1, 2025, NexStep Medical is compelled to prematurely terminate its ongoing clinical study.
- **Last updated:** 2025-01-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05153421

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05153421, "Evaluation of All'InCath in Peripheral Vasculature Percutaneous Transluminal Angioplasty.". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05153421. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*